文献速递糖尿病肥胖与代谢综合征

临床试验中治疗目标达成的种族/民族和社会经济差异:ACCORD试验的二次分析

Racial/ethnic and socioeconomic disparities in achievement of treatment goals within a clinical trial: a secondary analysis of the ACCORD trial.
PubMed 文献 · Diabetologia · 2023-09-16

该研究为ACCORD试验的二次分析,评估不同种族/民族和教育程度在达成糖尿病治疗目标上的差异。结果显示,与白人相比,黑人、西班牙裔和其他种族参与者达成血糖目标的调整比值比分别为0.63、0.73和0.82,黑人达成血压目标的调整比值比为0.77,但黑人、西班牙裔和其他种族达成甘油三酯降低的调整比值比分别为1.77、1.34和1.43。教育程度差异在调整基线特征后一般不显著。

要点

  • 黑人、西班牙裔和其他种族参与者达成血糖目标的aOR分别为0.63、0.73和0.82,低于白人。
  • 黑人参与者达成血压目标的aOR为0.77,低于白人;西班牙裔和其他种族与白人无显著差异。
  • 黑人、西班牙裔和其他种族达成甘油三酯降低的aOR分别为1.77、1.34和1.43,等于或高于白人。

核心结论

  • 在ACCORD试验中,种族/民族少数群体参与者较难达成高负担的血糖治疗目标,但达成低强度干预目标的可能性一般相似。
  • 血糖治疗目标达成差异部分由胰岛素剂量和口服药物使用差异介导,而非由低血糖、BMI变化或研究访视次数介导。

研究设计与样本

  • ACCORD试验(ClinicalTrials.gov NCT00000620)的二次分析,包含血糖(高负担)、血压(中等负担)和降甘油三酯(低负担)三种干预。
  • 采用多变量模型调整人口学和临床特征,按治疗组、种族/民族和教育程度分析第一年达成血糖目标、血压目标和甘油三酯降低≥25%的调整比值比,以及任何时间需要医疗救助的低血糖。
  • 探索低血糖、药物使用、BMI变化或研究访视次数是否介导血糖目标达成的差异。

主要发现

  • 与白人参与者相比,黑人、西班牙裔和其他种族参与者达成血糖目标的aOR(95%CI)分别为0.63(0.55,0.71)、0.73(0.61,0.88)、0.82(0.71,0.96)。
  • 黑人参与者达成血压目标的aOR(95%CI)为0.77(0.65,0.90),低于白人;西班牙裔和其他种族分别为1.01(0.78,1.32)和1.01(0.81,1.26),与白人无显著差异。
  • 黑人、西班牙裔和其他种族参与者达成甘油三酯降低的aOR(95%CI)分别为1.77(1.38,2.28)、1.34(0.98,1.84)、1.43(1.10,1.85),等于或高于白人。
  • 调整基线特征后,教育程度之间的目标达成差异一般不显著。
  • 需要医疗救助的低血糖发生率在黑人个体和教育程度较低者中最高。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Clinical trial participation should theoretically reduce barriers to care by ensuring medication and healthcare access. We aimed to evaluate disparities in achieving diabetes treatment targets by race/ethnicity and educational attainment within the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial (ClinicalTrials.gov NCT00000620). METHODS: The ACCORD trial included three interventions of varying participant burden: glycaemic (high burden), blood pressure (medium burden) and triglyceride-lowering (low burden). We examined adjusted odds ratios (aORs) for achievement of glycaemic targets, blood pressure targets and a ≥25% reduction in triglyceride levels (a proxy for adherence to fenofibrate therapy) in the first year, and for hypoglycaemia requiring medical assistance at any time, by treatment arm, race/ethnicity and educational attainment using multivariable models adjusted for demographics and clinical characteristics. We explored whether disparities in glycaemic goal achievement were mediated by hypoglycaemia, medication use, change in BMI or number of study visits attended. RESULTS: Compared with White participants, participants who identified as Black, Hispanic and Other race/ethnicity were less likely to achieve glycaemic targets (aOR [95% CI]) 0.63 [0.55,0.71], 0.73 [0.61, 0.88], 0.82 [0.71, 0.96], respectively); Black participants but not Hispanic and Other race/ethnicity participants were less likely to achieve blood pressure targets (aOR [95% CI] 0.77 [0.65, 0.90], 1.01 [0.78, 1.32], 1.01 [0.81, 1.26], respectively); and Black, Hispanic and Other race/ethnicity participants were equally or more likely to achieve triglyceride reduction (aOR [95% CI] 1.77 [1.38, 2.28], 1.34 [0.98, 1.84], 1.43 [1.10, 1.85], respectively). Differences in goal achievement by educational attainment were generally not significant after adjusting for baseline characteristics. Rates of hypoglycaemia requiring medical assistance were highest among Black individuals and those with lower educational attainment. Associations between race/ethnicity and glycaemic control were partially mediated by differences in insulin dosing and oral medication use. CONCLUSIONS/INTERPRETATION: Racially/ethnically minoritised participants in the ACCORD trial were less likely to achieve high-burden (glycaemic) treatment goals but were generally similarly likely to achieve goals of less intensive interventions. Differences in glycaemic treatment goal achievement were partially mediated by differences in medication use but not mediated by hypoglycaemia, change in BMI or study visit attendance.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Cromer SJ, Thaweethai T, Wexler DJ, et al. Racial/ethnic and socioeconomic disparities in achievement of treatment goals within a clinical trial: a secondary analysis of the ACCORD trial. Diabetologia. 2023. PMID: 37715820. doi:10.1007/s00125-023-05997-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。